AMBLYOPIA TREATMENT BEYOND OCCLUSION THERAPY: A REVIEW OF EMERGING THERAPEUTIC APPROACHES

Background: Amblyopia is a neurodevelopmental disorder of vision and a leading cause of monocular visual impairment in childhood. Standard management, refractive correction followed by occlusion (patching) or pharmacological penalization, is effective but constrained by poor adherence, psychosocial burden, residual deficits, recurrence after cessation, and diminishing response with age. Methods: A narrative review of the literature was conducted using PubMed/MEDLINE, Scopus, Web of Science and the Cochrane Library, prioritizing randomized controlled trials, systematic reviews and key mechanistic studies. Results: Five families of emerging approaches were identified: (1) binocular and dichoptic therapy, (2) perceptual learning and action video games, (3) pharmacological adjuncts (levodopa, citicoline and plasticity-modulating agents), (4) non-invasive brain stimulation, and (5) paradigms that reactivate cortical plasticity, such as dark exposure and brief monocular deprivation. A dichoptic digital therapeutic has shown benefit over spectacles alone in a controlled trial, but large pragmatic trials of binocular games have not shown superiority to part-time patching, and the largest levodopa trial found no added benefit. Evidence for stimulation and plasticity-reactivation approaches remains preliminary and is drawn mainly from small studies and animal models. Conclusion: Optical correction and occlusion or penalization remains first-line care. Binocular digital therapy is a reasonable alternative or adjunct when adherence is a concern, while other strategies require larger, sham-controlled trials with standardized outcomes and long-term follow-up.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-12
DOI
https://doi.org/10.5281/zenodo.24163887
Primary Topic
Ophthalmology and Visual Impairment Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

AMBLYOPIA TREATMENT BEYOND OCCLUSION THERAPY: A REVIEW OF EMERGING THERAPEUTIC APPROACHES

1*Hebah Mohammad Abbaas Al-Shraiedeh
Zenodo (CERN European Organization for Nuclear Research)
Ophthalmology and Visual Impairment Studies
article

AMBLYOPIA TREATMENT BEYOND OCCLUSION THERAPY: A REVIEW OF EMERGING THERAPEUTIC APPROACHES

1*Hebah Mohammad Abbaas Al-Shraiedeh
article en

Abstract

Background: Amblyopia is a neurodevelopmental disorder of vision and a leading cause of monocular visual impairment in childhood. Standard management, refractive correction followed by occlusion (patching) or pharmacological penalization, is effective but constrained by poor adherence, psychosocial burden, residual deficits, recurrence after cessation, and diminishing response with age. Methods: A narrative review of the literature was conducted using PubMed/MEDLINE, Scopus, Web of Science and the Cochrane Library, prioritizing randomized controlled trials, systematic reviews and key mechanistic studies. Results: Five families of emerging approaches were identified: (1) binocular and dichoptic therapy, (2) perceptual learning and action video games, (3) pharmacological adjuncts (levodopa, citicoline and plasticity-modulating agents), (4) non-invasive brain stimulation, and (5) paradigms that reactivate cortical plasticity, such as dark exposure and brief monocular deprivation. A dichoptic digital therapeutic has shown benefit over spectacles alone in a controlled trial, but large pragmatic trials of binocular games have not shown superiority to part-time patching, and the largest levodopa trial found no added benefit. Evidence for stimulation and plasticity-reactivation approaches remains preliminary and is drawn mainly from small studies and animal models. Conclusion: Optical correction and occlusion or penalization remains first-line care. Binocular digital therapy is a reasonable alternative or adjunct when adherence is a concern, while other strategies require larger, sham-controlled trials with standardized outcomes and long-term follow-up.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Ophthalmology and Visual Impairment Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon